中
  • Home

  • Company

    • Company
    • Corporate spirit
    • Our leadship
    • Our consultant
    • Our history
    • Social responsibility
  • Science

    • Our pipeline
    • Our focuses
    • R&D System
  • News

    • Company news
    • Media report
    • Industry information
  • Investors

    • Investment institutions
    • Information bulletin
  • Join us

    • Profile
    • Our cutlture
    • Highlight mechanism
    • Compensation and Benefits
    • Position vacant
  • Contact us

logo

Home

Company

  • Company
  • Corporate spirit
  • Our leadship
  • Our consultant
  • Our history
  • Social responsibility

Science

  • Our pipeline
  • Our focuses
  • R&D System

News

  • Company news
  • Media report
  • Industry information

Investors

  • Investment institutions
  • Information bulletin

Join us

  • Profile
  • Our cutlture
  • Highlight mechanism
  • Compensation and Benefits
  • Position vacant

Contact us

中
Home
News
Company news
  • Synnocare won the Outstanding Innovation Award of the second "New Drug Entrepreneurship in the Bay Area" activity

    Dr. Houxing Fan, founder and CEO of Synnocare, had the honor to participate in the second "New Drug Entrepreneurship in the Bay Area" project Roadshow & Investment and Financing Fair held in Qianwan Century Jinyuan Hotel, Ningbo on March 10, 2023.

    2023/03/11
  • Synnocare R&D Center is officially put into operation

    Synnocare R&D Center is officially put into operation. The pharmaceutical chemistry, biology, analysis and other departments are working closely and orderly.

    2022/07/30
  • 1
/upload/images/20220803/1684ac9be177d07947ab813278878e0c.jpg
Company profile
Research and Development
News
Investors
Join us
Contact us
Nanjing Synnocare Pharmaceutical Technology Co., Ltd

Address

021-58085058

hr@synnocare.com

official wechat
qrcode_for_gh_ae7817a32e15_258.jpg
Nanjing Synnocare Pharmaceutical Technology Co., Ltd.苏ICP备2022032127号